XY, LLC v. Trans Ova Genetics, LC, No. 19-1789 (Fed. Cir. July 31, 2020)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

XY, L LC, Beckman Coulter, Inc., and Inguran, LLC (collectively, “XY”) appeal the district court’s dismissal of certain patent-infringement allegations against Trans Ova Genetics, LC. The district court held asserted claims 1–23 of XY’s U.S. Patent No. RE46,559 ineligible under 35 U.S.C. § 101. The district court also held that XY’s pa- tent-infringement allegations with respect to certain claims of U.S. Patent Nos. 6,732,422, 7,723,116, and 8,652,769 were claim -precluded based on a prior lawsuit filed by XY against Trans Ova.